MX9709684A - Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. - Google Patents

Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.

Info

Publication number
MX9709684A
MX9709684A MX9709684A MX9709684A MX9709684A MX 9709684 A MX9709684 A MX 9709684A MX 9709684 A MX9709684 A MX 9709684A MX 9709684 A MX9709684 A MX 9709684A MX 9709684 A MX9709684 A MX 9709684A
Authority
MX
Mexico
Prior art keywords
vitamin
skin disorders
derivatives
treating skin
disorders
Prior art date
Application number
MX9709684A
Other languages
English (en)
Other versions
MXPA97009684A (es
Inventor
Joyce C Knutson
Charles W Bishop
Original Assignee
Bone Care Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Care Int Inc filed Critical Bone Care Int Inc
Publication of MX9709684A publication Critical patent/MX9709684A/es
Publication of MXPA97009684A publication Critical patent/MXPA97009684A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presenta invencion se refiere a la 1-alfa-hidroxi vitamina D4 y los análogos novedosos, 1,25-dihidroxi vitamina D4 y 1,24-dihidroxi vitamina D4 que son utiles como compuestos activos de composiciones farmacéuticas para el tratamiento de trastornos del metabolismo del calcio y diversos trastornos de la piel.
MXPA/A/1997/009684A 1995-06-07 1997-12-05 Uso de derivados de vitamina d4 para tratamientode trastornos de la piel MXPA97009684A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,342 US5763428A (en) 1990-09-21 1995-06-07 Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
US08484342 1995-06-07

Publications (2)

Publication Number Publication Date
MX9709684A true MX9709684A (es) 1998-06-28
MXPA97009684A MXPA97009684A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
CA2222591A1 (en) 1996-12-19
DE69631478D1 (de) 2004-03-11
WO1996040154A1 (en) 1996-12-19
US5763428A (en) 1998-06-09
EP0831838A1 (en) 1998-04-01
AU6256996A (en) 1996-12-30
JPH11506792A (ja) 1999-06-15
DE69631478T2 (de) 2004-11-25
ATE258796T1 (de) 2004-02-15
PL323798A1 (en) 1998-04-27
EP0831838B1 (en) 2004-02-04

Similar Documents

Publication Publication Date Title
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
ES2113635T3 (es) Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos.
SI0725779T1 (es)
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
MX9707535A (es) Uso de derivados de vitamina d2 o de vitamina d4 en la preparacion de un farmaco para el tratamiento de hiperparatiroidismo secundario.
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
BR9608488A (pt) Uso de derivados da vitamina d4 no tratamento de câncer
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
RU94040886A (ru) Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция
BG102667A (en) Diosgenine-containing composition
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
MX9800049A (es) Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
EP0744176A3 (en) Methods for inhibiting bone loss
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
GB9505082D0 (en) Medicament
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease